Metropolitan Life Insurance Company (MetLife)’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,037
| Closed | -$87.9K | – | 1617 |
|
|
2024
Q1 | $87.9K | Sell |
3,037
-315
| -9% | -$9.11K | ﹤0.01% | 1120 |
|
|
2023
Q4 | $76.9K | Hold |
3,352
| – | – | ﹤0.01% | 1220 |
|
|
2023
Q3 | $55.9K | Buy |
3,352
+389
| +13% | +$6.49K | ﹤0.01% | 1339 |
|
|
2023
Q2 | $81.8K | Buy |
2,963
+443
| +18% | +$12.2K | ﹤0.01% | 1126 |
|
|
2023
Q1 | $58K | Sell |
2,520
-401
| -14% | -$9.22K | ﹤0.01% | 1310 |
|
|
2022
Q4 | $31.9K | Hold |
2,921
| – | – | ﹤0.01% | 1756 |
|
|
2022
Q3 | $24.6K | Hold |
2,921
| – | – | ﹤0.01% | 1912 |
|
|
2022
Q2 | $23.1K | Hold |
2,921
| – | – | ﹤0.01% | 1977 |
|
|
2022
Q1 | $69.2K | Sell |
2,921
-8,826
| -75% | -$209K | ﹤0.01% | 1409 |
|
|
2021
Q4 | $402K | Hold |
11,747
| – | – | 0.01% | 1569 |
|
|
2021
Q3 | $208K | Buy |
11,747
+195
| +2% | +$3.46K | ﹤0.01% | 2034 |
|
|
2021
Q2 | $518K | Buy |
11,552
+2,268
| +24% | +$102K | 0.01% | 1500 |
|
|
2021
Q1 | $240K | Hold |
9,284
| – | – | ﹤0.01% | 1889 |
|
|
2020
Q4 | $187K | Hold |
9,284
| – | – | ﹤0.01% | 1979 |
|
|
2020
Q3 | $182K | Buy |
9,284
+1,829
| +25% | +$35.8K | ﹤0.01% | 1833 |
|
|
2020
Q2 | $132K | Buy |
+7,455
| New | +$132K | ﹤0.01% | 2090 |
|
|
2019
Q4 | – | Sell |
-6,617
| Closed | -$79.5K | – | 2552 |
|
|
2019
Q3 | $79.5K | Buy |
+6,617
| New | +$79.5K | ﹤0.01% | 2427 |
|